Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9203161rdf:typepubmed:Citationlld:pubmed
pubmed-article:9203161lifeskim:mentionsumls-concept:C0014834lld:lifeskim
pubmed-article:9203161lifeskim:mentionsumls-concept:C0015690lld:lifeskim
pubmed-article:9203161lifeskim:mentionsumls-concept:C0085403lld:lifeskim
pubmed-article:9203161lifeskim:mentionsumls-concept:C0443286lld:lifeskim
pubmed-article:9203161lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9203161lifeskim:mentionsumls-concept:C0013171lld:lifeskim
pubmed-article:9203161lifeskim:mentionsumls-concept:C0000901lld:lifeskim
pubmed-article:9203161lifeskim:mentionsumls-concept:C0185125lld:lifeskim
pubmed-article:9203161lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:9203161lifeskim:mentionsumls-concept:C0525895lld:lifeskim
pubmed-article:9203161pubmed:issue3lld:pubmed
pubmed-article:9203161pubmed:dateCreated1997-8-7lld:pubmed
pubmed-article:9203161pubmed:abstractTextMenadione and dimethyl maleate, Michael reaction acceptors, induced N-ethylmaleimide (NEM) reductase activity in Escherichia coli strain DH5a. Linoleic acid also induced NEM reductase activity, but oleic acid, which is less susceptible to lipid peroxidation than linoleic acid, did not induce NEM reductase activity. In addition, NEM reductase activity was induced by menadione and linoleic acid also in strain DH5, Y1088 and Y1090. Linoleic acid is not a Michael reaction acceptor, but is known to produce Michael reaction acceptors such as alkenals and 4-hydroxyalkenals as a result of free-radical-initiated lipid peroxidation. Thus, our findings suggested that lipid peroxidation was involved in the induction of NEM reductase by linoleic acid. The electrophilic property of Michael reaction acceptors provides the signal for induction of phase II enzymes such as glutathione S-transferase and quinone reductase in mammals. The inducer potency of phase II enzymes has been used to design chemoprotective drugs. Therefore, the inducible nature of this enzyme will serve not only for the elucidation of its physiological function, but also for the evaluation of chemoprotective drugs.lld:pubmed
pubmed-article:9203161pubmed:languageenglld:pubmed
pubmed-article:9203161pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9203161pubmed:citationSubsetIMlld:pubmed
pubmed-article:9203161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9203161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9203161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9203161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9203161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9203161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9203161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9203161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9203161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9203161pubmed:statusMEDLINElld:pubmed
pubmed-article:9203161pubmed:monthAprlld:pubmed
pubmed-article:9203161pubmed:issn0379-0355lld:pubmed
pubmed-article:9203161pubmed:authorpubmed-author:SuzukiHHlld:pubmed
pubmed-article:9203161pubmed:authorpubmed-author:MiuraKKlld:pubmed
pubmed-article:9203161pubmed:authorpubmed-author:MizugakiMMlld:pubmed
pubmed-article:9203161pubmed:authorpubmed-author:TomiokaYYlld:pubmed
pubmed-article:9203161pubmed:authorpubmed-author:HoshiYYlld:pubmed
pubmed-article:9203161pubmed:authorpubmed-author:YonezawaMMlld:pubmed
pubmed-article:9203161pubmed:authorpubmed-author:HishinumaTTlld:pubmed
pubmed-article:9203161pubmed:issnTypePrintlld:pubmed
pubmed-article:9203161pubmed:volume19lld:pubmed
pubmed-article:9203161pubmed:ownerNLMlld:pubmed
pubmed-article:9203161pubmed:authorsCompleteYlld:pubmed
pubmed-article:9203161pubmed:pagination147-51lld:pubmed
pubmed-article:9203161pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9203161pubmed:meshHeadingpubmed-meshheading:9203161-...lld:pubmed
pubmed-article:9203161pubmed:meshHeadingpubmed-meshheading:9203161-...lld:pubmed
pubmed-article:9203161pubmed:meshHeadingpubmed-meshheading:9203161-...lld:pubmed
pubmed-article:9203161pubmed:meshHeadingpubmed-meshheading:9203161-...lld:pubmed
pubmed-article:9203161pubmed:meshHeadingpubmed-meshheading:9203161-...lld:pubmed
pubmed-article:9203161pubmed:meshHeadingpubmed-meshheading:9203161-...lld:pubmed
pubmed-article:9203161pubmed:meshHeadingpubmed-meshheading:9203161-...lld:pubmed
pubmed-article:9203161pubmed:meshHeadingpubmed-meshheading:9203161-...lld:pubmed
pubmed-article:9203161pubmed:meshHeadingpubmed-meshheading:9203161-...lld:pubmed
pubmed-article:9203161pubmed:meshHeadingpubmed-meshheading:9203161-...lld:pubmed
pubmed-article:9203161pubmed:meshHeadingpubmed-meshheading:9203161-...lld:pubmed
pubmed-article:9203161pubmed:year1997lld:pubmed
pubmed-article:9203161pubmed:articleTitleThe effects of unsaturated fatty acids, oxidizing agents and Michael reaction acceptors on the induction of N-ethylmaleimide reductase in Escherichia coli: possible application for drug design of chemoprotectors.lld:pubmed
pubmed-article:9203161pubmed:affiliationDepartment of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Japan.lld:pubmed
pubmed-article:9203161pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:946164entrezgene:pubmedpubmed-article:9203161lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9203161lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9203161lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9203161lld:pubmed